The Massachusetts Alternative Simplified Research Credit: A Comprehensive Analysis of the ASC Calculation and Regulatory Framework

The Massachusetts Alternative Simplified Credit (ASC) calculation determines a tax incentive equal to 10% of the current year’s qualified research expenses that exceed 50% of the taxpayer’s average research spending over the previous three taxable years. This methodology provides a streamlined alternative to the traditional research credit by substituting complex historical gross receipts data with a rolling average of recent research expenditures conducted within the Commonwealth.1

The introduction of the Alternative Simplified Method (ASM), frequently referred to in industry practice as the ASC, represents a fundamental shift in how the Commonwealth of Massachusetts incentivizes corporate innovation. Enacted as part of the 2014 Economic Development Act, this calculation method was designed to address systemic barriers that prevented many high-growth and established corporations from accessing the research credit under the pre-existing “Regular Method”.3 For decades, the Massachusetts research credit, governed by M.G.L. c. 63, § 38M, was tethered to a “fixed-base percentage” that often required documentation from the mid-1980s—a requirement that proved insurmountable for many modern technology and life sciences firms.1 By decoupling the incentive from long-term gross receipts and historical research-to-revenue ratios, the ASC calculation focuses exclusively on the incremental growth of a company’s research footprint within the state’s borders.5 This report provides an exhaustive analysis of the technical mechanics of the ASC calculation, the regulatory guidance issued by the Massachusetts Department of Revenue (DOR), and the strategic implications for corporations navigating the Commonwealth’s tax landscape.

The Evolution of the Massachusetts Research Incentive

The Massachusetts research credit was first introduced in 1991 to encourage corporations to anchor their research and development activities within the state.6 Historically, the credit closely followed the federal research credit available under Section 41 of the Internal Revenue Code (IRC) as it existed on August 12, 1991.1 This traditional framework mandated an incremental credit based on the excess of current-year qualified research expenses (QREs) over a “base amount”.1

For over twenty years, the primary hurdle for taxpayers was the calculation of the “fixed-base percentage,” which for established firms was based on the ratio of aggregate QREs to aggregate gross receipts for the period between 1984 and 1988.5 Taxpayers who could not provide adequate records for this period were often forced to use the maximum statutory fixed-base percentage of 16%, which frequently resulted in a “base amount” so high that it effectively zeroed out any potential credit.2

Recognizing that this data-heavy requirement was stifling the incentive’s effectiveness, the Massachusetts Legislature passed “An Act Promoting Economic Growth Across the Commonwealth” (St. 2014, c. 287).3 This legislation rewrote Section 38M to simplify the traditional credit calculation and, more importantly, introduced the Alternative Simplified Method.3 The ASC method, mirroring the federal ASC introduced years earlier, provides a “low-barrier” entry point for taxpayers with volatile spending patterns, high revenue growth, or limited historical records.5

Statutory Foundation: M.G.L. Chapter 63 Section 38M

The legal authority for the research credit resides in Massachusetts General Law Chapter 63, Section 38M.1 The statute establishes that a business corporation is entitled to a credit against its corporate excise equal to the sum of 10% of the excess of qualified research expenses over the base amount, plus 15% of basic research payments determined under IRC § 41(e)(1)(A).1

Section 38M specifically delineates the two calculation options available for tax years beginning on or after January 1, 2015.1 The “Traditional Method” remains available under subsection (a), while the ASC option is established under subsection (b).1 The statute explicitly mandates that the terms “qualified research expenses,” “basic research payment,” and “credit year” shall have the same meanings as under Section 41 of the Code, unless the context requires otherwise.1

The Mechanics of the Alternative Simplified Credit (ASC)

The defining characteristic of the ASC is its “rolling base,” which allows the credit calculation to adapt to the taxpayer’s recent financial history rather than static data from decades past.5 Under this method, the “base amount” is defined as 50% of the average QREs over the three taxable years preceding the credit year.1

The 50% Threshold and Rolling Three-Year Average

The core formula for the ASC credit for tax years beginning on or after January 1, 2021, is expressed mathematically as follows:

$$Credit = 0.10 \times \left$$

In this equation:

• $QRE_{current}$ represents the qualified research expenses incurred in Massachusetts during the taxable year.1
• $QRE_{n-i}$ represents the qualified research expenses for each of the three years immediately preceding the current tax year.1

The “50% of the average” component is a deliberate policy choice modeled after the federal ASC.3 It effectively creates a lower “floor” for the credit to kick in. A taxpayer does not necessarily need to increase their research spending over the previous year to receive a credit; they simply need to exceed half of their recent average.25 This is particularly advantageous for businesses with cyclical R&D cycles or those experiencing a temporary plateau in research investment.5

Calculation for Taxpayers Without Prior QREs

For many emerging technology companies or companies newly entering the Massachusetts market, the three-year look-back period may contain years with zero research expenses.1 The statute provides a specific “safe harbor” for these instances. If a taxpayer did not have qualified research expenses in any one of the three taxable years preceding the credit year, the credit is calculated as 5% of the taxpayer’s current-year qualified research expenses.1

This “no-prior-QRE” rule acts as a “deemed” credit rate that bypasses the “excess over base” requirement.1 It ensures that the incentive is available from day one of a company’s research operations in the Commonwealth, supporting early-stage startups that have not yet established a three-year baseline.5

Phase-In Rates and Long-Term Value

While the current ASC rate is 10%, the legislature implemented a phased approach to manage the transition from the old regime.3 This phase-in allowed the Department of Revenue to monitor the fiscal impact on the state budget while giving businesses time to adjust their tax planning strategies.3

Regulatory Guidance from the Department of Revenue

The successful application of the ASC method requires a nuanced understanding of the technical releases and proposed regulations issued by the Massachusetts Department of Revenue. These documents provide the “connective tissue” between the broad language of the statute and the specific line items on a tax return.2

Technical Information Release (TIR) 14-13 and 14-16

TIR 14-13 was the primary vehicle for explaining the 2014 legislative changes.2 It clarified that the new ASC generally conforms to the methodology of the federal credit as it existed in early 2014.3 This alignment with federal standards was critical because it allowed tax professionals to leverage existing federal documentation for state compliance.5

TIR 14-16 followed shortly thereafter to provide technical corrections regarding the phase-in schedule.2 It resolved a drafting ambiguity in the original act, confirming that for the middle phase (2018–2020), the 7.5% rate was to be applied to the excess QREs over 50% of the three-year average, rather than a separate calculation.4 These releases established the “ground rules” for the first years of the ASC.4

Proposed Regulation 830 CMR 63.38M.2

To provide a more comprehensive framework, the DOR drafted Proposed Regulation 830 CMR 63.38M.2.2 This document is the most detailed source of guidance available, covering everything from the definition of a “controlled group” to specific accounting rules for research expenses.8

While officially categorized as “proposed,” the regulation provides the authoritative interpretation used by the Commissioner in audits and for the creation of tax forms like Schedule RC.8 It explains that for all purposes under the regulation, corporations must use the same method of accounting to compute the Massachusetts credit as they use for the federal credit under Section 41.8 This “conformity rule” simplifies the internal record-keeping required for multi-state corporations.5

Documentation and Record-Keeping Requirements

Compliance with the ASC method requires more than just a calculation; it demands robust substantiation.8 Regulation 830 CMR 63.38M.2(16) stipulates that corporations must maintain adequate records to substantiate the calculation of the credit, including the QREs for both the current year and the three preceding base-period years.8

The DOR recommends that taxpayers retain project descriptions, payroll records identifying researchers, invoices for R&D supplies, and contracts for outside research services.16 Because the statute of limitations for an audit is generally three years after a return is filed, practitioners often suggest maintaining these records for five to seven years, particularly since the ASC calculation relies on a three-year historical window.16

Defining Massachusetts Qualified Research Expenses

The threshold for a “qualified” expense in Massachusetts is two-fold: the expense must meet federal Section 41(b) definitions and the research must be conducted specifically within the Commonwealth.2 This “geographic nexus” is the most common point of contention during tax audits.8

Eligible Categories of Research Expenses

The Department of Revenue recognizes four primary clusters of research expenditures that can be included in the ASC calculation.8

For an activity to qualify, it must pass the “Four-Part Test” derived from IRC § 41(d).11 The research must be intended to develop a new or improved business component; it must be technological in nature; it must aim to eliminate uncertainty regarding the design or capability of the component; and it must involve a process of experimentation.11 In the Massachusetts context, the focus is on whether the personnel and facilities involved in this four-part process were physically located in the state.8

The Limitation Framework: $25,000 Threshold and 75% Ceiling

The Massachusetts research credit is designed to reward investment while ensuring a minimum level of state tax revenue.8 To achieve this balance, the law imposes complex limitations on how much credit can be used in a single tax year.1

The Corporate Excise Cap Calculation

A corporation’s research credit usage is limited by two main tiers of its tax liability.1

1. Full Utilization Tier: The first $25,000 of a corporation’s excise liability can be offset 100% by the research credit.1
2. Partial Utilization Tier: Any excise liability in excess of $25,000 can only be offset by up to 75%.1

Furthermore, the credit cannot reduce a corporation’s total excise below the minimum tax of $456.2

Indefinite vs. Fifteen-Year Carryforwards

The interaction between these limitations creates two different carryforward categories.6

• Fifteen-Year Carryforward: Credits that are generated but cannot be used because the taxpayer has no tax liability, or because they exceed the 15-year limit for other reasons, generally expire after 15 years.6
• Indefinite Carryforward: Credits that are specifically disallowed because of the 75% rule (i.e., they would have been used if the cap were 100% of the liability) can be carried forward indefinitely.6 This provision ensures that high-innovation companies with large, recurring credit generations are not permanently penalized for their success.16

Example of Limitation Application

Consider a corporation with an excise liability of $100,000 and a generated research credit (via ASC) of $90,000.2

• The first $25,000 is fully offset, leaving $75,000 of excise.8
• The remaining $75,000 of excise is subject to the 75% limit: $75,000 \times 0.75 = $56,250.8
• The total credit the corporation can use this year is $\$25,000 + \$56,250 = \$81,250$.8
• The unused credit portion is $\$90,000 – \$81,250 = \$8,750$.8
• Because this $8,750 was disallowed solely by the 75% limitation, it is eligible for indefinite carryforward.6

Aggregation and Controlled Group Dynamics

A critical component of Massachusetts research credit compliance is the aggregation rule.1 The Commissioner of Revenue is authorized to aggregate the activities of all corporations that are members of a controlled group, as defined by IRC § 41(f)(1)(A).1 This applies whether or not all members are doing business in Massachusetts.8

The Aggregate Calculation Process

For groups under common control, the ASC is calculated as if the group were a single entity.2 The steps are as follows:

1. Sum the Massachusetts QREs for all group members for the current taxable year.8
2. Sum the Massachusetts QREs for all group members for the three preceding taxable years.8
3. Calculate the group’s “base amount” (50% of the group’s average three-year QREs).8
4. Apply the 10% rate to the group’s excess QREs over the group base.8
5. Allocate the resulting credit back to each individual member corporation based on its share of the group’s total current-year Massachusetts QREs.2

This aggregation prevents groups from “spinning off” high-research divisions to trigger the 5% “new taxpayer” credit rate or from shifting expenses between entities to manipulate the three-year average.15 Inter-company payments for research between group members are eliminated from the calculation to avoid double-counting.2

Sharing the $25,000 Limitation

Just as the credit is calculated on an aggregate basis, the $25,000 threshold for the 100% utilization tier is also shared.1 Each corporation in an aggregated group is allowed a portion of the $25,000 bracket determined by the ratio of that corporation’s separately determined excise to the total excise for all members of the group.2

Comprehensive Case Study: ASC vs. Regular Method

To fully understand the meaning of the ASC calculation, it is helpful to contrast it with the Regular Method in a realistic corporate scenario.2 Suppose “Nexus Biotech,” a Massachusetts-based company, is evaluating its 2024 tax position.

Data Points for Nexus Biotech

• 2024 MA QREs: $2,000,000
• Prior 3-Year QREs (2021-2023): $1,500,000 (avg. $1.5M/year)
• Average Annual Gross Receipts (prior 4 years): $20,000,000
• Fixed-Base Ratio (Regular Method): 12% (established via historical records)

Calculation 1: The ASC Method

1. Average QRE (3 years): $1,500,000 1
2. Base Amount (50%): $750,000 1
3. Excess QRE: $\$2,000,000 – \$750,000 = \$1,250,000$ 1
4. ASC Credit (10%): $\$1,250,000 \times 0.10 = \$125,000$ 1

Calculation 2: The Regular Method

1. Average Receipts (4 years): $20,000,000 1
2. Fixed-Base Ratio: 12% 1
3. Regular Base Amount: $\$20,000,000 \times 0.12 = \$2,400,000$ 1
4. Excess QRE: $\$2,000,000 – \$2,400,000 = \$0$ (no credit) 1

Strategic Insight

In this scenario, Nexus Biotech is a high-revenue company whose research spending, while substantial ($2M), does not meet the 12% research-to-revenue ratio established in its historical base period.5 Under the Regular Method, it would receive zero credit.5 However, the ASC method ignores the $20 million in revenue and focuses only on the fact that the company spent significantly more this year than its recent $1.5 million average.5 The ASC method generates a $125,000 credit, demonstrating why it has become the preferred choice for established companies with significant revenue.5

Administrative Procedures and Compliance

Navigating the Massachusetts research credit requires adherence to specific filing protocols and deadlines established by the Department of Revenue.2

Filing Schedule RC

All corporations claiming the research credit must file Schedule RC.2 The schedule requires the taxpayer to select between Option 1 (Traditional) and Option 2 (ASM/ASC) in the header.2 Once an option is chosen for a given tax year, it generally cannot be changed on an amended return if the credit was already claimed.16 However, federal Treasury Decision 9666 has introduced some flexibility for amended returns where no credit was previously claimed, a nuance that practitioners must carefully monitor for state-level conformity.27

The Massachusetts Gross Receipts Election

For companies choosing either method, a critical election exists regarding gross receipts.2 Taxpayers can elect to calculate their base amount using either federal gross receipts or only Massachusetts-sourced gross receipts.2 Under 830 CMR 63.38M.1(5)(d), this election is binding for three consecutive taxable years.2 This prevents “cherry-picking” of data to inflate the credit in a single year.16

Electronic Notification and TIR 14-16

TIR 14-16 also introduced modernized notice provisions.4 The Department of Revenue is now permitted to give electronic notices rather than paper notices to taxpayers who consent.4 This shift toward electronic communication is part of a broader DOR initiative (MassTaxConnect) to streamline tax administration for the Commonwealth’s business community.4

Economic Impact and Tax Expenditure Statistics

The research credit is one of the most significant “tax expenditures” in the Massachusetts budget, representing hundreds of millions of dollars in foregone revenue that the state views as an investment in future growth.7

Revenue and Participation Trends

The Department of Revenue’s Tax Expenditure Reports provide a glimpse into the scale of the incentive.7 For Fiscal Year 2024, total net state tax revenues from corporations were approximately $4.23 billion.32 The research credit significantly offsets this total, particularly for the Commonwealth’s core innovation industries.16

The 2025 Outlook

The Fiscal Year 2025 Tax Expenditure Budget continues to support the research credit as a primary tool for economic development.7 While total state tax collections grew by approximately 7.1% in the most recent fiscal year, the Commonwealth remains committed to maintaining the permanent status of the research credit to provide stability for long-term corporate planning.6

Special Provisions for Life Sciences and Manufacturing

The Massachusetts research credit does not exist in a vacuum; it is part of a broader suite of incentives tailored to specific high-value sectors.6

Life Sciences Refundability

While the standard research credit is non-refundable, the Massachusetts Life Sciences Center (MLSC) administers a program that can make the credit refundable for certified companies.11 Under M.G.L. c. 63, § 38W, certified life sciences companies may request a refund of up to 90% of their unused research credits.2 This is a critical lifeline for pre-revenue biotech startups that have high research costs but no tax liability to offset.16

Interaction with Investment Tax Credits (ITC)

Manufacturing corporations and R&D corporations often qualify for a 3% Investment Tax Credit for tangible property (labs, machinery, etc.) purchased and used in Massachusetts.6 Regulation 830 CMR 63.38M.2 provides guidance on how these credits interact, ensuring that a single expenditure does not result in a “double benefit” while allowing companies to maximize their total incentive package through careful categorization of expenses.8

Conclusion

The Massachusetts Alternative Simplified Credit calculation represents a vital modernization of the Commonwealth’s tax code, replacing an antiquated, data-heavy traditional method with a forward-looking, rolling-average incentive.5 By establishing the credit as 10% of the excess QREs over 50% of the three-year average, the law creates a sustainable and accessible mechanism for businesses of all sizes to recover a portion of their innovation costs.1 The Department of Revenue’s guidance, particularly through TIR 14-16 and Proposed Regulation 830 CMR 63.38M.2, has provided the necessary technical clarity for corporations to implement this calculation with confidence.4 As Massachusetts continues to compete globally for research investment, the ASC serves as a predictable and permanent cornerstone of the state’s commitment to its innovation economy.6 For practitioners and corporate leaders, mastering the nuances of the ASC calculation—from geographic nexus rules to the indefinite carryforward of disallowed portions—remains essential for optimizing tax efficiency and fueling the next generation of scientific and technological breakthroughs in the Commonwealth.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/